Techcyte today announced that Sonora Quest Laboratories, one of the largest integrated laboratory systems in the United States, has gone live with the Techcyte Fusion ® Parasitology Suite (for ...

Quest Diagnostics is back in focus after analysts lifted Fair Value estimates from US$223.44 to US$239.38, a move that has ...

Quest Diagnostics (NYSE:DGX) reported second-quarter financial results on Thursday. The transcript from the company's ...

Quest Diagnostics (DGX) came out with quarterly earnings of $3.12 per share, beating the Zacks Consensus Estimate of $2.81 ...

Quest Diagnostics put up a definitive beat Thursday, driven by solid demand across its consumer division, leading the stock to surge.

Quest Laboratories Limited is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, ...

Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests Quest Diagnostics (NYSE:DGX) reported double-digit revenue ...

(DGX) on Thursday reported second-quarter earnings of $320 million. The Secaucus, New Jersey-based company said it had net ...

Quest Diagnostics, the world’s leading provider of diagnostic information services, said demand for COVID-19 tests “continues ...

"We now expect revenues to be between $11.95 billion and $12.05 billion... Reported EPS to be in a range of $9.97 to $10.17 and adjusted EPS in a range of $11.05 to $11.25." (Executive VP & CFO Samad) ...

Second quarter revenues of $3.04 billion, up 10.2% from 2025, with 10.0% organic revenue growth Second quarter reported diluted earnings per share ("EPS") of $2.84 ...

Quest Diagnostics completed its acquisition of select assets from Fresenius Medical Care’s laboratory business. As part of the transaction, the Secaucus-based testing provider will now offer ...